Table 2.
A list of targeting materials and the targeted tumor
| Target tumor | Targeting material | Target receptor | Reference |
|---|---|---|---|
|
| |||
| Human colon (HCT116) | IFLLWQR (IF7) (peptide) | Annexin 1 (anxa1) | 148 |
| B16 Melanoma | YIGSR (peptide) | Laminin receptor | 149 |
| Ovarian, breast, prostate carcinomas | LHRH peptide | LHRH receptor | 11 |
| Various cancer types | VNTANST (peptide) | Vimentin | 150,151 |
| B16F10 | RGDGW (peptide) | α5β1 integrin | 152 |
| Prostate carcinoma | F77 (mAb) | Prostate specific glycolipid (PCLA) | 153 |
| Hepatocellular carcinoma | SP94 (peptide) | Unknown | 16 |
| Hepatocellular carcinoma | FQHPSFI (HCBP1) (peptide) | Unknown | 154 |
| Lung (H640, A549 and H226) | CSNIDARAC (peptide) | EGF receptor (under research) | 155 |
| Breast cancer | CTCE-9908 | CXCR4 | 156 |
| Metastatic melanoma | SB505124 | TGF-β | 5 |